Xiao-bo ZHANG, Zheng-yu JIN. Does Acute Cerebral Venous Sinus Thrombosis Require Endovascular Treatment?[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(2): 140-143. DOI: 10.3969/j.issn.1674-9081.20190271
Citation: Xiao-bo ZHANG, Zheng-yu JIN. Does Acute Cerebral Venous Sinus Thrombosis Require Endovascular Treatment?[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(2): 140-143. DOI: 10.3969/j.issn.1674-9081.20190271

Does Acute Cerebral Venous Sinus Thrombosis Require Endovascular Treatment?

More Information
  • Corresponding author:

    JIN Zheng-yu Tel: 86-10-69159562, E-mail: jin_zhengyu@163.com

  • Received Date: December 05, 2019
  • Issue Publish Date: March 29, 2020
  • Cerebral venous sinus thrombosis(CVST) is rare and accounts for less than 1% of strokes. The mainstay treatment for CVST is systemic anticoagulation with heparin, but 9%-13% of patients have a poor outcome. In patients who show signs of rapid deterioration, endovascular treatment(ET) is technically feasible and has shown benefit with good recanalization rates in different case series and prospective cohorts. However, it remains unknown whether it improves the clinical outcome of the ET subgroup compared with anticoagulation alone. Therefore, whether acute CVST requires endovascular therapy remains controversial.
  • [1]
    Ruiz-Sandoval JL, Chiquete E, Banuelos-Becerra LJ, et al. Cerebral venous thrombosis in a Mexican multicenter registry of acute cerebrovascular disease:the RENAMEVASC study[J]. J Stroke Cerebrovasc Dis, 2012, 21:395-400. DOI: 10.1016/j.jstrokecerebrovasdis.2011.01.001
    [2]
    Stam J. Thrombosis of the cerebral veins and sinuses[J]. N Engl J Med, 2005, 352:1791-1798. DOI: 10.1056/NEJMra042354
    [3]
    Saposnik G, Barinagarrementeria F, Brown RD Jr, et al. Diagnosis and management of cerebral venous thrombosis:a statement for healthcare professionals from the American heart association/American stroke association[J]. Stroke, 2011, 42:1158-1192. DOI: 10.1161/STR.0b013e31820a8364
    [4]
    Einhaupl KM, Villringer A, Meister W, et al. Heparin treatment in sinus venous thrombosis[J]. Lancet, 1991, 338:597-600. DOI: 10.1016/0140-6736(91)90607-Q
    [5]
    Ferro JM, Canhao P, Stam J, et al. Prognosis of cerebral vein and dural sinus thrombosis:results of the International Study on Cerebral Vein and Dural Sinus Thrombosis(ISCVT)[J]. Stroke, 2004, 35:664-670. DOI: 10.1161/01.STR.0000117571.76197.26
    [6]
    Canhão P, Falcão F, Ferro JM. Thrombolytics for cerebral sinus thrombosis:a systematic review[J]. Cerebrovasc Dis, 2003, 15:159-166. DOI: 10.1159/000068833
    [7]
    Stam J, Majoie CB, van Delden OM, et al. Endovascular thrombectomy and thrombolysis for severe cerebral sinus thrombosis:a prospective study[J]. Stroke, 2008, 39:1487-1490. DOI: 10.1161/STROKEAHA.107.502658
    [8]
    Mohammadian R, Sohrabi B, Mansourizadeh R, et al. Treatment of progressive cerebral sinuses thrombosis with local thrombolysis[J]. Interv Neuroradiol, 2012, 18:89-96. DOI: 10.1177/159101991201800112
    [9]
    Rahman M, Velat GJ, Hoh BL, et al. Direct thrombolysis for cerebral venous sinus thrombosis[J]. Neurosurg Focus, 2009, 27:E7. http://www.ncbi.nlm.nih.gov/pubmed/19877797
    [10]
    Li G, Zeng X, Hussain M, et al. Safety and validity of mechanical thrombectomy and thrombolysis on severe cerebral venous sinus thrombosis[J]. Neurosurgery, 2013, 72:730-738. DOI: 10.1227/NEU.0b013e318285c1d3
    [11]
    Lee SK, Mokin M, Hetts SW, et al. Current endovascular strategies for cerebral venous thrombosis:report of the SNIS Standards and Guidelines Committee[J]. J Neurointerv Surg, 2018, 10:803-810. DOI: 10.1136/neurintsurg-2018-013973
    [12]
    Ferro JM, Bousser MG, Canhão P, et al. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis-Endorsed by the European Academy of Neurology[J]. Eur Stroke J, 2017, 2:195-221. DOI: 10.1177/2396987317719364
    [13]
    Coutinho JM, Ferro JM, Zuurbier SM, et al. Thrombolysis or anticoagulation for cerebral venous thrombosis:rationale and design of the TO-ACT trial[J]. Int J Stroke, 2013, 8:135-140. DOI: 10.1111/j.1747-4949.2011.00753.x
    [14]
    Siddiqui FM, WeberMW, Dandapat S, et al. Endovascular thrombolysis or thrombectomy for cerebral venous thrombosis:study of Nationwide Inpatient Sample 2004-2014[J]. J Stroke Cerebrovasc Dis, 2019, 28:1440-1447. DOI: 10.1016/j.jstrokecerebrovasdis.2019.03.025
    [15]
    Siddiqui FM, Dandapat S, Banerjee C, et al. Mechanical thrombectomy in cerebral venous thrombosis:systematic review of 185 cases[J]. Stroke, 2015, 46:1263-1268. DOI: 10.1161/STROKEAHA.114.007465
    [16]
    Gurley MB, King TS, Tsai FY. Sigmoid sinus thrombosis associated with internal jugular venous occlusion:direct thrombolytic treatment[J]. J Endovasc Surg, 1996, 3:306-314. DOI: 10.1583/1074-6218(1996)003<0306:SSTAWI>2.0.CO;2
    [17]
    Dowd CF, Malek AM, Phatouros CC, et al. Application of a rheolytic thrombectomy device in the treatment of dural sinus thrombosis:a new technique[J]. Am J Neuroradiol, 1999, 20:568-570. http://www.ncbi.nlm.nih.gov/pubmed/10319961
    [18]
    Choulakian A, Alexander MJ. Mechanical thrombectomy with the penumbra system for treatment of venous sinus thrombosis[J]. J Neurointerv Surg, 2010, 2:153-156. DOI: 10.1136/jnis.2009.001651
    [19]
    Siddiqui FM, Pride GL, Lee JD. Use of the Penumbra system 054 plus low dose thrombolytic infusion for multifocal venous sinus thrombosis. A report of two cases[J]. Interv Neuroradiol, 2012, 18:314-319. DOI: 10.1177/159101991201800311
    [20]
    Dandapat S, Samaniego EA, Szeder V, et al. Safety and efficacy of the use of large bore intermediate suction catheters alone or in combination for the treatment of acute cerebral venous sinus thrombosis:A multicenter experience[J]. Interv Neuroradiol, 2020, 26:26-32. DOI: 10.1177/1591019919865957
    [21]
    Tsang ACO, Hwang AC, Chiu RHY, et al. Combined aspiration thrombectomy and continuous intrasinus thrombolysis for cerebral venous sinus thrombosis:technical note and case series[J].Neuroradiology, 2018, 60:1093-1096. DOI: 10.1007/s00234-018-2084-3
    [22]
    洪霞.医患共同决策[J].协和医学杂志, 2018, 9:277-280. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=xhyx201803018
  • Related Articles

    [1]LEI Zhenyun, XUE Guozhong, LIU Zhenhua, ZHANG Xinli. Research progress on action mechanism of NLRP3 inflammasome and pyroptosis in diabetic nephropathy[J]. Medical Journal of Peking Union Medical College Hospital. DOI: 10.12290/xhyxzz.2024-0543
    [2]YAN Xinchun, HUO Li. Evaluation of Von Hippel-Lindau Syndrome Through Novel Small Molecular Tracer 68Ga-NY104 PET/CT Imaging[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(4): 911-915. DOI: 10.12290/xhyxzz.2024-0216
    [3]HUANG Lu, WU Youbin, NI Yiran, LIU Mengyuan, WU Jiangfeng, ZHANG Yanqiong. The Mechanism of miRNAs in Liver Fibrosis[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(6): 1251-1257. DOI: 10.12290/xhyxzz.2023-0125
    [4]Rare Diseases Society of Chinese Research Hospital Association, National Rare Diseases Committee, Beijing Rare Disease Diagnosis, Treatment and Protection Society, Gitelman Syndrome Consensus Working Group. Expert Consensus for the Diagnosis and Treatment of Gitelman Syndrome in China (2021)[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(6): 902-912. DOI: 10.12290/xhyxzz.2021-0555
    [5]Reziya ABUDUXUKUER, Shan LYU, Yao-de HE, Hang JIN, Zhen-ni GUO, Yi YANG. Rearch Course of Reperfusion Therapy for Acute Ischemic Stroke[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(2): 162-169. DOI: 10.3969/j.issn.1674-9081.20190273
    [6]Hao GUO, Wen-da WANG, Yi CAI, Yu-shi ZHANG. Progress in Research on MicroRNA in Tuberous Sclerosis Complex Related Diseases[J]. Medical Journal of Peking Union Medical College Hospital, 2017, 8(4-5): 283-288. DOI: 10.3969/j.issn.1674-9081.2017.05.017
    [7]Ming-sheng MA, Xü-de ZHANG, Min WEI, Shi-min ZHAO, Zheng-qing QIU. Efficacy of Low Dose Corticosteroid Therapy in Duchenne Muscular Dystrophy[J]. Medical Journal of Peking Union Medical College Hospital, 2014, 5(4): 384-388. DOI: 10.3969/j.issn.1674-9081.2014.04.006
    [8]Ying ZHANG, Jin-song GAO, Jun-tao LIU, Hai-yuan LIU, Ying-na SONG, Xiao-ming GONG, Zhi-jing SUN. Effectiveness of B-lynch Suture in Treatment and Prevention of Postpartum Hemorrhage[J]. Medical Journal of Peking Union Medical College Hospital, 2013, 4(2): 174-177. DOI: 10.3969/j.issn.1674-9081.2013.02.019
    [9]Jie LIU, Yue-ping ZENG, Chun-xia HE, Qin LONG, Hong-zhong JIN, Qiu-ning SUN. Corticosteroids plus Intravenous Immunoglobulin in the Treatment of 7 Cases with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis[J]. Medical Journal of Peking Union Medical College Hospital, 2012, 3(4): 381-385. DOI: 10.3969/j.issn.1674-9081.2012.04.004
    [10]Shuai TANG, Jie YI, Yu-guang HUANG. Cardiovascular Responses of Intubation with Shikani Seeing Optical Stylet and Macintosh Laryngoscope[J]. Medical Journal of Peking Union Medical College Hospital, 2012, 3(3): 314-317. DOI: 10.3969/j.issn.1674-9081.2012.03.015
  • Cited by

    Periodical cited type(1)

    1. 侯丽敏,刘芳艳,孟雪,李思颉. 急性缺血性脑卒中和颅内静脉窦及脑静脉血栓形成患者血管内治疗术后发生下肢深静脉血栓形成的影响因素及其预测指标研究. 实用心脑肺血管病杂志. 2021(10): 42-46+52 .

    Other cited types(2)

Catalog

    Article Metrics

    Article views (426) PDF downloads (76) Cited by(3)
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return
    x Close Forever Close